These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 25953156
1. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. Choi M, Jo H, Park HJ, Sateesh Kumar A, Lee J, Yun J, Kim Y, Han SB, Jung JK, Cho J, Lee K, Kwak JH, Lee H. Bioorg Med Chem Lett; 2015 Jun 15; 25(12):2545-9. PubMed ID: 25953156 [Abstract] [Full Text] [Related]
2. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents. Choi M, Jo H, Kim D, Yun J, Kang JS, Kim Y, Jung JK, Hong JT, Cho J, Kwak JH, Lee H. Arch Pharm Res; 2016 May 15; 39(5):618-30. PubMed ID: 27021311 [Abstract] [Full Text] [Related]
3. Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors. Choi M, Hwang YS, Kumar AS, Jo H, Jeong Y, Oh Y, Lee J, Yun J, Kim Y, Han SB, Jung JK, Cho J, Lee H. Bioorg Med Chem Lett; 2014 Jun 01; 24(11):2404-7. PubMed ID: 24792464 [Abstract] [Full Text] [Related]
4. Synthesis and nuclear factor-kappaB inhibitory activities of 6- or 7-methylchroman-2-carboxylic acid N-(substituted) phenylamides. Kwak JH, Won SW, Kim TJ, Yi W, Choi EH, Kim SC, Park H, Roh E, Jung JK, Hwang BY, Hong JT, Kim Y, Cho J, Lee H. Arch Pharm Res; 2009 Feb 01; 32(2):167-75. PubMed ID: 19280144 [Abstract] [Full Text] [Related]
5. Structure-activity relationship of indoline-2-carboxylic acid N-(substituted)phenylamide derivatives. Kwak JH, Kim Y, Park H, Jang JY, Lee KK, Yi W, Kwak JA, Park SG, Kim H, Lee K, Kang JS, Han SB, Hwang BY, Hong JT, Jung JK, Kim Y, Cho J, Lee H. Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4620-3. PubMed ID: 20579876 [Abstract] [Full Text] [Related]
6. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line. Lim JC, Jeyaraj EJ, Sagineedu SR, Wong WS, Stanslas J. Pharmacology; 2015 Aug 01; 95(1-2):70-7. PubMed ID: 25613753 [Abstract] [Full Text] [Related]
7. Antiproliferative potency of novel benzofuran-2-carboxamides on tumour cell lines: cell death mechanisms and determination of crystal structure. Hranjec M, Sović I, Ratkaj I, Pavlović G, Ilić N, Valjalo L, Pavelić K, Kraljević Pavelić S, Karminski-Zamola G. Eur J Med Chem; 2013 Jan 01; 59():111-9. PubMed ID: 23220640 [Abstract] [Full Text] [Related]
8. Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: design, synthesis and biological screening. Suthar SK, Jaiswal V, Lohan S, Bansal S, Chaudhary A, Tiwari A, Alex AT, Joesph A. Eur J Med Chem; 2013 May 01; 63():589-602. PubMed ID: 23548704 [Abstract] [Full Text] [Related]
9. Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway. Sim S, Lee S, Ko S, Phuong Bui B, Linh Nguyen P, Cho J, Lee K, Kang JS, Jung JK, Lee H. Bioorg Med Chem; 2021 Sep 15; 46():116371. PubMed ID: 34500188 [Abstract] [Full Text] [Related]
10. Design and synthesis of pregnenolone/2-cyanoacryloyl conjugates with dual NF-κB inhibitory and anti-proliferative activities. Song JL, Zhang J, Liu CL, Liu C, Zhu KK, Yang FF, Liu XG, Figueiró Longo JP, Alexandre Muehlmann L, Azevedo RB, Zhang YY, Guo YW, Jiang CS, Zhang H. Bioorg Med Chem Lett; 2017 Oct 15; 27(20):4682-4686. PubMed ID: 28919340 [Abstract] [Full Text] [Related]
11. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines. Li N, Xin WY, Yao BR, Cong W, Wang CH, Hou GG. Eur J Med Chem; 2018 Jul 15; 155():531-544. PubMed ID: 29909338 [Abstract] [Full Text] [Related]
12. Rugulactone derivatives act as inhibitors of NF-κB activation and modulates the transcription of NF-κB dependent genes in MDA-MB-231cells. Mohapatra DK, Reddy DS, Ramaiah MJ, Ghosh S, Pothula V, Lunavath S, Thomas S, Valli SN, Bhadra MP, Yadav JS. Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1389-96. PubMed ID: 24508135 [Abstract] [Full Text] [Related]
13. Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents. Giri RS, Thaker HM, Giordano T, Williams J, Rogers D, Vasu KK, Sudarsanam V. Bioorg Med Chem; 2010 Apr 01; 18(7):2796-808. PubMed ID: 20335039 [Abstract] [Full Text] [Related]
14. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents. Kumar V, Mudgal MM, Rani N, Jha A, Jaggi M, Singh AT, Sanna VK, Singh P, Sharma PK, Irchhaiya R, Burman AC. J Enzyme Inhib Med Chem; 2009 Jun 01; 24(3):763-70. PubMed ID: 18720190 [Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of dihydrobenzofuran lignans and related compounds as potential antitumor agents that inhibit tubulin polymerization. Pieters L, Van Dyck S, Gao M, Bai R, Hamel E, Vlietinck A, Lemière G. J Med Chem; 1999 Dec 30; 42(26):5475-81. PubMed ID: 10639289 [Abstract] [Full Text] [Related]